Literature DB >> 21267806

[Clinical utility of an antimicrobial blocking solution in patients with an indwelling catheter].

J Pannek1, A-M Vestweber.   

Abstract

OBJECTIVE: Patients with indwelling catheters have a substantial long-term risk for catheter incrustation and blockage. Chronic bacteriuria is regarded as a risk factor for this complication. Until today, there are no effective prophylactic measures. We evaluated the effect of a triclosan-containing fluid for inflation of the catheter balloons (Farco-fill® Protect) on the extent of bacteriuria in a clinical setting. PATIENTS AND METHODS: In a prospective multicentre study, between 7 / 2009 and 3 / 2010, the effect of Farco-fill® Protect on urine culture was evaluated in 62 patients with indwelling catheters.
RESULTS: 55 patients could be completely evaluated. With use of Farco-fill® Protect, urinary pH, and urine volume / 24 hours remained unchanged. The number of patients with > 10 (5) colony forming units / mL was reduced from 70.9 % to 45.5 %. In 34.5 % the extent of catheter incrustations could be reduced.
CONCLUSION: This study is the first to demonstrate a marked reduction of bacteriuria and catheter incrustations with the help of a triclosan-containing fluid in a clinical setting. Long-term studies are necessary to determine whether or not the afore-mentioned effect leads to less catheter occlusions.This finding would have positive medical as well as economic aspects. © Georg Thieme Verlag KG Stuttgart ˙ New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267806     DOI: 10.1055/s-0030-1262758

Source DB:  PubMed          Journal:  Aktuelle Urol        ISSN: 0001-7868            Impact factor:   0.658


  2 in total

1.  [Investigation of the use of triclosan in patients with indwelling catheters: a randomized, double blind, multicenter, placebo-controlled clinical study].

Authors:  H Sperling; A Eisenhardt; E Mumperow; O Gralla; G Lümmen; K Seidali; A Hinke; T Jäger
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

2.  An external ventricular drainage catheter impregnated with rifampicin, trimethoprim and triclosan, with extended activity against MDR Gram-negative bacteria: an in vitro and in vivo study.

Authors:  Roger Bayston; Waheed Ashraf; Ivan Pelegrin; Katherine Fowkes; Alison S Bienemann; William G B Singleton; Ian S Scott
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.